Heterozygote advantage of the MTHFR gene in patients with neural-tube defect and their relatives
- PMID: 10326541
- DOI: 10.1016/s0140-6736(05)61119-1
Heterozygote advantage of the MTHFR gene in patients with neural-tube defect and their relatives
Similar articles
-
Methylenetetrahydrofolate reductase mutation and neural tube defects.Lancet. 1996 Oct 12;348(9033):1037-8. doi: 10.1016/S0140-6736(05)64971-9. Lancet. 1996. PMID: 8855891 No abstract available.
-
5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects.Am J Med Genet. 1996 Jun 28;63(4):610-4. doi: 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.0.CO;2-L. Am J Med Genet. 1996. PMID: 8826441
-
No evidence for heterozygote advantage at MTHFR in patients with lumbosacral myelomeningocele or their relatives.Genet Med. 2004 Jan-Feb;6(1):69-70. doi: 10.1097/01.gim.0000106162.27561.68. Genet Med. 2004. PMID: 14726815 No abstract available.
-
[Polymorphism of the methylenetetrahydrofolate reductase gene (MTHFR) and incidence of hyperhomocysteinemia-related diseases].Postepy Hig Med Dosw. 2001;55(2):233-56. Postepy Hig Med Dosw. 2001. PMID: 11468972 Review. Polish.
-
[Genetic risk factors of neural tube defects].Med Wieku Rozwoj. 2002 Oct-Dec;6(4):349-70. Med Wieku Rozwoj. 2002. PMID: 12810987 Review. Polish.
Cited by
-
Genetic thromobophilia in pregnancy: a case-control study among North Indian women.J Thromb Thrombolysis. 2013 Feb;35(2):250-6. doi: 10.1007/s11239-012-0797-4. J Thromb Thrombolysis. 2013. PMID: 22918664
-
Folate supplementation, MTHFR gene polymorphism and neural tube defects: a community based case control study in North India.Metab Brain Dis. 2011 Sep;26(3):241-6. doi: 10.1007/s11011-011-9256-8. Epub 2011 Jul 27. Metab Brain Dis. 2011. PMID: 21792640
-
A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group.Am J Hum Genet. 2002 Nov;71(5):1207-15. doi: 10.1086/344213. Epub 2002 Oct 16. Am J Hum Genet. 2002. PMID: 12384833 Free PMC article.
-
Heterozygote advantage of methylenetetrahydrofolate reductase polymorphisms on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy.Tumour Biol. 2014 Nov;35(11):11159-70. doi: 10.1007/s13277-014-2427-6. Epub 2014 Aug 8. Tumour Biol. 2014. PMID: 25104092
-
The methylenetethrahydrofolate reductase (MTHFR) C677T polymorphism and male infertility in Italy.J Endocrinol Invest. 2003 Jul;26(7):620-2. doi: 10.1007/BF03347018. J Endocrinol Invest. 2003. PMID: 14594111
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical